Substrates for peptidase S01.142: duodenase
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Angiotensin-1 | P01019 | 34-43 | Peptide-Phe41+His-Leu | N | NT | Ile | His | Pro | Phe | His | Leu | - | - | Pemberton et al., 1997 | ||
Angiotensin-1 | P01019 | 34-43 | Asp-Arg-Val-Tyr37+Ile-Peptide | N | NT | Asp | Arg | Val | Tyr | Ile | His | Pro | Phe | Pemberton et al., 1997 | ||
arginyl bond | peptide-Arg+peptide | N | - | - | NPe | Arg | CPe | - | - | - | ||||||
Bradykinin | P01042 | 381-389 | Peptide-Phe388+Arg | N | NT | Phe | Ser | Pro | Phe | Arg | - | - | - | Pemberton et al., 1997 | ||
Fibrinogen beta chain | P02676 | 22-468 | Peptide-Lys28+Lys-Peptide | N | MS | Pro | Tyr | Asp | Lys | Lys | Lys | Glu | Glu | Pemberton et al., 1997 | ||
Insulin B chain (oxidized) | P01308 | 25-54 | Peptide-Leu39+Tyr-Peptide | N | NT | Val | Glu | Ala | Leu | Tyr | Leu | Val | Cys | Pemberton et al., 1997 | ||
leucyl bond | peptide-Leu+peptide | N | - | - | NPe | Leu | CPe | - | - | - | ||||||
lysyl bond | peptide-Lys+peptide | N | - | - | NPe | Lys | CPe | - | - | - | ||||||
phenylalanyl bond | peptide-Phe+peptide | N | - | - | NPe | Phe | CPe | - | - | - | ||||||
Serum albumin | P02769 | 25-607 | Peptide-Lys138+Leu-Peptide | N | NT | Asp | Leu | Pro | Lys | Leu | Lys | Pro | Asp | Pemberton et al., 1997 | ||
Serum albumin | P02769 | 25-607 | Peptide-Lys263+Val-Peptide | N | NT | Asp | Leu | Thr | Lys | Val | His | Lys | Glu | Pemberton et al., 1997 | ||
Serum albumin | P02769 | 25-607 | Peptide-Lys285+Tyr-Peptide | N | NT | Asp | Leu | Ala | Lys | Tyr | Ile | Cys | Asp | Pemberton et al., 1997 | ||
Serum albumin | P02769 | 25-607 | Peptide-Lys401+His-Peptide | N | NT | Asp | Lys | Leu | Lys | His | Leu | Val | Asp | Pemberton et al., 1997 | ||
Substance P | P20366 | 58-68 | Peptide-Phe64+Phe-Gly-Leu-Met | N | NT | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Met | Pemberton et al., 1997 | ||
Substance P | P20366 | 58-68 | Peptide-Leu67+Met | N | NT | Phe | Phe | Gly | Leu | Met | - | - | - | Pemberton et al., 1997 | ||
Suc-Phe-Leu-Phe-SBzl | Suc-Phe-Leu-Phe+SBzl | S | Suc | Phe | Leu | Phe | SBz | - | - | - | ||||||
Tos-Gly-Pro-Lys-NHPhNO2 | Tos-Gly-Pro-Lys+NHPhNO2 | S | Tos | Gly | Pro | Lys | NAN | - | - | - | ||||||
tyrosyl bond | peptide-Tyr+peptide | N | - | - | NPe | Tyr | CPe | - | - | - | ||||||
Z-Lys-SBzl | Z-Lys+SBzl | S | - | - | Z | Lys | SBz | - | - | - |